[Use of mindronate in cardiac insufficiency in patients with ischemic heart disease]. 1990

L I Ol'binskaia, and G M Golokolenova

A clinical trial of Soviet drug mildronate has proved its antiarrhythmic action, the ability to prevent ventricular extrasystoles, to reduce asthenia, to enhance physical performance and adaptive reactions. The heart rate decrease appeared insignificant. Intravenous administration of the drug improves myocardial contractility. Mildronate is well tolerated. No side effects were registered.

UI MeSH Term Description Entries
D008297 Male Males
D008763 Methylhydrazines Hydrazines substituted by one or more methyl groups in any position.
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002311 Cardiomyopathy, Dilated A form of CARDIAC MUSCLE disease that is characterized by ventricular dilation, VENTRICULAR DYSFUNCTION, and HEART FAILURE. Risk factors include SMOKING; ALCOHOL DRINKING; HYPERTENSION; INFECTION; PREGNANCY; and mutations in the LMNA gene encoding LAMIN TYPE A, a NUCLEAR LAMINA protein. Cardiomyopathy, Congestive,Congestive Cardiomyopathy,Dilated Cardiomyopathy,Cardiomyopathy, Dilated, 1a,Cardiomyopathy, Dilated, Autosomal Recessive,Cardiomyopathy, Dilated, CMD1A,Cardiomyopathy, Dilated, LMNA,Cardiomyopathy, Dilated, With Conduction Defect 1,Cardiomyopathy, Dilated, with Conduction Deffect1,Cardiomyopathy, Familial Idiopathic,Cardiomyopathy, Idiopathic Dilated,Cardiomyopathies, Congestive,Cardiomyopathies, Dilated,Cardiomyopathies, Familial Idiopathic,Cardiomyopathies, Idiopathic Dilated,Congestive Cardiomyopathies,Dilated Cardiomyopathies,Dilated Cardiomyopathies, Idiopathic,Dilated Cardiomyopathy, Idiopathic,Familial Idiopathic Cardiomyopathies,Familial Idiopathic Cardiomyopathy,Idiopathic Cardiomyopathies, Familial,Idiopathic Cardiomyopathy, Familial,Idiopathic Dilated Cardiomyopathies,Idiopathic Dilated Cardiomyopathy
D002986 Clinical Trials as Topic Works about pre-planned studies of the safety, efficacy, or optimum dosage schedule (if appropriate) of one or more diagnostic, therapeutic, or prophylactic drugs, devices, or techniques selected according to predetermined criteria of eligibility and observed for predefined evidence of favorable and unfavorable effects. This concept includes clinical trials conducted both in the U.S. and in other countries. Clinical Trial as Topic
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005260 Female Females
D006439 Hemodynamics The movement and the forces involved in the movement of the blood through the CARDIOVASCULAR SYSTEM. Hemodynamic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults

Related Publications

L I Ol'binskaia, and G M Golokolenova
November 1985, Vrachebnoe delo,
L I Ol'binskaia, and G M Golokolenova
July 1976, Kardiologiia,
L I Ol'binskaia, and G M Golokolenova
January 1987, Vestnik Akademii meditsinskikh nauk SSSR,
L I Ol'binskaia, and G M Golokolenova
January 1983, Vrachebnoe delo,
L I Ol'binskaia, and G M Golokolenova
November 1990, Archives des maladies du coeur et des vaisseaux,
L I Ol'binskaia, and G M Golokolenova
June 1991, Vrachebnoe delo,
L I Ol'binskaia, and G M Golokolenova
January 1974, Terapevticheskii arkhiv,
L I Ol'binskaia, and G M Golokolenova
January 1981, Revista espanola de cardiologia,
L I Ol'binskaia, and G M Golokolenova
November 1979, Casopis lekaru ceskych,
Copied contents to your clipboard!